Study design
nausea
This study had a double-blind, randomized crossover design. Participants received pramipexole and placebo in separate sessions at least seven days apart (mean interval 40.4 ± 34.2 days). At each session, they received 10-mg domperidone in a non-blind fashion to antagonize nausea and other potential side effects induced by pramipexole [